Clinical trial
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular…
NCT00190580 · KVT-Study Group, Other · Completed
Key facts
| NCT number | NCT00190580 |
|---|---|
| Title | Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease |
| Official title | Effects of Valsartan on the Progression of Renal and Cardiovascular Disease - Kanagawa Valsartan Trial (KVT) |
| Lead sponsor | KVT-Study Group, Other |
| Collaborators | Tokai University Yokohama City University Showa University Kitasato University St. Marianna University School of Medicine |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Hypertension |
| Intervention type | Drug |
| Interventions | valsartan, Conventional antihypertensive drugs |
| Enrollment | 312 |
| Start date | Feb 1, 2003 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Mar 31, 2015 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: